10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2012 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 113,205 | 97,688 | 94,503 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (90,032) | (75,148) | (73,143) |
| Cash paid to other suppliers and employees | (13,643) | (13,635) | (13,778) |
| Interest received | 4 | 4 | 4 |
| Interest paid | (581) | (647) | (583) |
| Income taxes paid | (2,282) | (2,406) | (2,224) |
| Net cash provided by operating activities | 6,671 | 5,856 | 4,779 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,030) | (1,872) | (2,005) |
| Proceeds from sale-leaseback transactions | 529 | 592 | 507 |
| Proceeds from sale of property and equipment | 23 | 4 | 34 |
| Acquisitions (net of cash acquired) and other investments | (378) | (1,441) | (177) |
| Purchase of available-for-sale investments | (3) | ||
| Maturity of available-for-sale investments | 60 | 1 | |
| Proceeds from sale of subsidiary | 7 | 250 | |
| Net cash used in investing activities | (1,849) | (2,410) | (1,640) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (60) | 450 | (15) |
| Proceeds from issuance of long-term debt | 1,239 | 1,463 | 991 |
| Repayments of long-term debt | (1,718) | (2,122) | (2,103) |
| Purchase of noncontrolling interest in subsidiary | (26) | ||
| Dividends paid | (829) | (674) | (479) |
| Derivative settlements | (19) | (5) | |
| Proceeds from exercise of stock options | 836 | 431 | 285 |
| Excess tax benefits from stock-based compensation | 28 | 21 | 28 |
| Repurchase of common stock | (4,330) | (3,001) | (1,500) |
| Other | (9) | ||
| Net cash used in financing activities | (4,860) | (3,460) | (2,798) |
| Net increase (decrease) in cash and cash equivalents | (38) | (14) | 341 |
| Cash and cash equivalents at the beginning of the year | 1,413 | 1,427 | |
| Cash and cash equivalents at the end of the year | 1,375 | 1,413 | 1,427 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 3,875 | 3,457 | 3,424 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,753 | 1,568 | 1,469 |
| Stock-based compensation | 132 | 135 | 150 |
| Loss on early extinguishment of debt | 348 | ||
| Gain on sale of subsidiary | (53) | ||
| Deferred income taxes and other noncash items | (106) | 144 | 30 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (387) | (748) | 532 |
| Inventories | (858) | 607 | (352) |
| Other current assets | 3 | (420) | (4) |
| Other assets | (99) | (49) | (210) |
| Accounts payable and claims and discounts payable | 1,147 | 1,128 | (40) |
| Accrued expenses | 753 | 85 | (176) |
| Other long-term liabilities | 110 | 2 | (44) |
| Net cash provided by operating activities | 6,671 | 5,856 | 4,779 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |